Literature DB >> 23620452

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

Pier Luigi Zinzani1, Cinzia Pellegrini, Enrico Derenzini, Lisa Argnani, Stefano Pileri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23620452     DOI： 10.1002/hon.2049

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  5 in total

1.  L-PROBe: A Novel Non-anthracycline Combination Chemotherapy Regimen for Aggressive B Cell Non-Hodgkin Lymphoma in Elderly Patients.

Authors:  Arjun Datt Law; Gaurav Prakash; Alka Khadwal; Ashim Das; Subhash Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-06       Impact factor: 0.900

2.  Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab.

Authors:  Pier Luigi Zinzani; Cinzia Pellegrini; Lisa Argnani; Alessandro Broccoli
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

3.  Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities.

Authors:  Athena Kritharis; Michael Coyle; Jaya Sharma; Andrew M Evens
Journal:  Blood       Date:  2015-03-03       Impact factor: 22.113

Review 4.  Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma.

Authors:  John G Gribben; Nathan Fowler; Franck Morschhauser
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

5.  Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report.

Authors:  Katarzyna Krawczyk; Wojciech Jurczak; Krystyna Gałązka; Andrzej Gruchała; Aleksander B Skotnicki
Journal:  J Med Case Rep       Date:  2014-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.